Technical Appendix
We next investigated to what extent observed differences in penicillin resistance prevalence could be attributed to:
1. Spatial heterogeneity in serotype distributions (Std1), 2. Serotype-specific prevalence of penicillin resistance (Std2).
We standardized the observed prevalence of penicillin resistance in each state, adjusting for each of the two factors Std1 and Std2 (1, 2) . We performed an inverse-variance weighted 
Results
A total of 3,746 pneumococcal isolates of all serotypes were collected in 2009 and 2,740 in 2012, of which a total of 1,312 (35.02%) and 1,488 (54.31%) were NVTs respectively. The increase in proportion of IPD cases resulting from NVTs was significant (p < 0.05) in all but one state (California, p = 0.057), which might be attributable to the removal of VT in the population although serotype replacement may also be playing a role. The five most common NVTs collected in 2009 were 22F (n = 249; 19% of all NVTs), 33F (n = 119; 9%), 23A (n = 114; 9%), 16F (n = 111; 9%) and 15A (n = 109; 9%), while 2012 was dominated by serotypes 22F (n = 333; 22%), 09N (n = 117; 8%), 33F (n = 115; 8%), 35B (n = 114; 8%) and 15BC (n = 108; 7%). Figures 2 and 3) .
The introduction of serotype-specific pneumococcal vaccines can result in large fluctuations in the structure and dynamics of pneumococcal populations. Serotype replacement may partially offset the benefits of vaccination over the long term until a PCV targeting additional serotypes is implemented, as was observed with PCV7 (4). While no replacement disease has yet been reported following PCV13, the potential for increasing resistance in NVT is of great concern, particularly since serotype replacement has been reported in pneumococcal carriage (5-7). Previous studies of NVTs have reported that vaccines have altered the population structure of NVTs through serotype replacement (8) (9) (10) (11) . During the post-PCV7 period, there was an observed increase in PNSP among NVTs (12) (13) (14) , but the underlying causes are not fully understood. In serotypes 15A, 23A, and 35B, penicillin nonsusceptibility shifted in the post-PCV7 era mainly as a consequence of shifts of clonal populations within individual serotypes that were comprised of distinct susceptible and nonsusceptible clonal complexes (13) , but other factors might explain increased resistance in other serotypes. Understanding this is critical as it is anticipated that a complete or near complete replacement of the PCV13 serotypes in carriage is likely to occur once the population has regained equilibrium, as was observed in different parts of the United States after PCV7 implementation (5, (15) (16) (17) . While the antibiotic resistance profiles of the replacing NVTs from disease are known, as NVTs become more common over time greater exposure to antibiotics may produce selection for increased resistance. In this study, we found that while prevalence of PNSP remained largely constant following PCV13 introduction, there was much geographic heterogeneity and variation by serotype, which should be monitored closely to detect emerging threats.
We implemented the standardization method used by McCormick and colleagues to analyze the pre-PCV7 pneumococcus dataset from the ABCs system (1). The same method was also used by Link-Gelles to compare the pre-PCV7 and post-PCV7 pneumococcal populations (2) . In both studies, standardized proportions were calculated to reflect either the differences in serotype composition or the differences in proportions of resistance against penicillin and erythromycin within individual serotypes, in their contribution to the prevalence of PNSP at each sample site. In contrast to the two previous studies in which the whole sampled pneumococcus population was analyzed and all serotypes were included, we standardized the geographic differences in penicillin resistance as a proportion of the NVT population only.
Two factors play an important role in producing the geographic variation in the proportion of penicillin resistance: differences in the serotype composition and differences in the proportions of penicillin resistance within individual serotypes, which is primarily due to selection of pre-existing resistant clones within serotype. Our results suggest that both have equally contributed to the observed variation before the introduction of PCV13, but serotype distribution played a slightly greater role post-vaccine. The contribution of serotype distribution is likely influenced by changes in the distribution of VT, such that antibiotic pressure is applied only to the serotypes currently circulating at any given point in time.
Our results were in contrast to a similar study conducted on the population before PCV7 use that showed geographic variation in penicillin resistance is attributable primarily to withinserotype proportions of penicillin resistance -and hence implicated differences in antibiotic use among sites (1). However, our results for 2009 were similar to those reported by Link-Gelles and colleagues for pneumococcus collected in the later years of post-PCV7 (2007-09) (2) , indicating that both factors drive the geographic variation in penicillin resistance when the population is close to equilibrium.
Our standardization results for 2012 were also in direct contrast to those reported for the years immediately following PCV7 introduction (2002-06) (2). Although both factors remain important during these time periods, our study shows that serotype composition played a slightly greater role, while the previous study reported a greater contribution by the differences in the proportion of penicillin resistance within each serotype. Two reasons may explain the disparity between our results and those of Link-Gelles and colleagues (2) . First, since our focus was only on NVTs, rather than both VT and NVT isolates as used in the previous study (n = 6,929), the small sampling size in our study naturally leads to increased uncertainty. Alternatively, shortterm dynamics may be different between the two groups of serotypes. We can suggest that immediately following PCV implementation, there is a rapid and stochastic shuffling of different genotypes within the local population at each site as a result of the opening up of new niches following the elimination of VTs, and which NVTs are involved at each site will depend on which happened to be present before vaccination. For the VTs remaining in the population postvaccine, differences in the proportion of penicillin resistance within individual serotypes remain as the primary driving factor mainly because some of these VTs, despite the declining numbers, continue to be present in relatively higher frequencies when the population has still not yet reached equilibrium. This is the case for serotype 19A, which remains an important diseasecausing and highly resistant serotype, even though it has declined in frequency during the early post-PCV13 period and NVTs are now primarily detected (11, 18) . Hence, the geographic variation in penicillin resistance of NVTs will therefore largely depend on which NVTs were present in the population before the vaccine was implemented, even if they occurred initially at very low frequencies.
One limitation of our study is that we did not consider the effects of serotype-specific differences in the proportion of penicillin resistance by age group (14) . This variation may also be affected by differences in antibiotic pressure due to differences in antibiotic consumption between children and adults (19) . While our study provides a quantifiable assessment of the relative contributions of serotype distribution and serotype-specific proportions of penicillin resistance in NVT, future investigation should focus on age-related differences in resistance to specifically identify the underlying causes of such variation. 
